Bill
HB 1169
classify medetomidine as a Schedule III controlled substance and establish permissible uses.
2026 Regular Session
Introduced by Bobbi Andera and 9 co-sponsors
South Dakota reclassifies medetomidine as Schedule III controlled substance while permitting established medical and veterinary uses.
Signed by the Governor on 2026-03-09 H.J. 534